
NCX-4016
CAS No. 175033-36-0
NCX-4016( Nitroaspirin | NO-Aspirin )
Catalog No. M12651 CAS No. 175033-36-0
NCX-4016 (Nitroaspirin;NO-Aspirin 1) is a nitroderivative of aspirin that combines cyclooxygenase inhibitor with an NO donor, directly and irreversiblely inhibits COX-1.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 200 | Get Quote |
![]() ![]() |
5MG | 302 | Get Quote |
![]() ![]() |
10MG | 410 | Get Quote |
![]() ![]() |
25MG | 626 | Get Quote |
![]() ![]() |
50MG | 771 | Get Quote |
![]() ![]() |
100MG | 1062 | Get Quote |
![]() ![]() |
200MG | 1431 | Get Quote |
![]() ![]() |
500MG | 2124 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNCX-4016
-
NoteResearch use only, not for human use.
-
Brief DescriptionNCX-4016 (Nitroaspirin;NO-Aspirin 1) is a nitroderivative of aspirin that combines cyclooxygenase inhibitor with an NO donor, directly and irreversiblely inhibits COX-1.
-
DescriptionNCX-4016 (Nitroaspirin;NO-Aspirin 1) is a nitroderivative of aspirin that combines cyclooxygenase inhibitor with an NO donor, directly and irreversiblely inhibits COX-1; suppresses platelet activation, platelet aggregation and thromboxane A2 production, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat.Diabetes Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsNitroaspirin | NO-Aspirin
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number175033-36-0
-
Formula Weight331.28
-
Molecular FormulaC16H13NO7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1=CC=CC=C1CO[N+]([O-])=O)C2=CC=CC=C2OC(C)=O
-
Chemical Name2-(Acetyloxy)-benzoic acid 3-[(nitrooxy)methyl]phenyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Corazzi T, et al. J Pharmacol Exp Ther. 2005 Dec;315(3):1331-7.
2. Rossoni G, et al. J Pharmacol Exp Ther. 2001 Apr;297(1):380-7.
3. Lechi C, et al. Thromb Haemost. 1996 Nov;76(5):791-8.
molnova catalog



related products
-
Lornoxicam
Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.
-
Rebamipide mofetil
Rebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
-
Salicylic acid
Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity.